Monitoring the safety of high-dose, trivalent influenza vaccine in the vaccine adverse event reporting system (VAERS), 2010-2018

被引：0
|
作者：
Moro, Pedro [1 ]
Lewis, Paige [1 ]
Cano, Maria [1 ]
机构：
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
802
引用
收藏
页码：388 / 389
页数：2
相关论文
共 50 条
  • [1] Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011-2019
    Moro, Pedro L.
    Woo, Emily Jane
    Marquez, Paige
    Cano, Maria
    [J]. VACCINE, 2020, 38 (37) : 5923 - 5926
  • [2] Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
    Shimabukuro, Tom T.
    Nguyen, Michael
    Martin, David
    DeStefano, Frank
    [J]. VACCINE, 2015, 33 (36) : 4398 - 4405
  • [3] The role of the vaccine adverse event reporting system (VAERS) in monitoring vaccine safety
    Iskander, JK
    Miller, ER
    Chen, RT
    [J]. PEDIATRIC ANNALS, 2004, 33 (09): : 599 - 606
  • [4] Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010
    Moro, Pedro L.
    Arana, Jorge
    Cano, Maria
    Menschik, David
    Yue, Xin
    Lewis, Paige
    Haber, Penina
    Martin, David
    Broder, Karen
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (11) : 1608 - 1614
  • [5] Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
    Woo, Emily Jane
    Moro, Pedro L.
    [J]. VACCINE, 2022, 40 (07) : 1026 - 1030
  • [6] Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
    Woo, Emily Jane
    Moro, Pedro L.
    Cano, Maria
    Jankosky, Christopher
    [J]. VACCINE, 2017, 35 (42) : 5618 - 5621
  • [7] Safety of trivalent Adjuvanted influenza vaccine (aIIV3; Fluad), vaccine adverse event reporting system (VAERS), United States, July 2016-June 2018
    Haber, Penina
    Moro, Pedro
    Ng, Carmen
    Dores, Graca M.
    Page, Lewis
    Cano, Maria
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 392 - 393
  • [8] Clinical Patterns of Adverse Events after High-Dose Influenza Vaccine Reported to the Vaccine Adverse Event Reporting System
    Moro, Pedro L.
    Arana, Jorge
    Cano, Maria
    Lewis, Paige
    Haber, Penina
    Menschik, David
    Martin, David
    Broder, Karen
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S362 - S362
  • [9] THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS)
    CHEN, RT
    RASTOGI, SC
    MULLEN, JR
    HAYES, SW
    COCHI, SL
    DONLON, JA
    WASSILAK, SG
    [J]. VACCINE, 1994, 12 (06) : 542 - 550
  • [10] High-dose trivalent influenza vaccine: safety and immunogenicity
    Ortiz de Lejarazu, Raul
    Martinon Torres, Federico
    Gil de Miguel, Angel
    Diez Domingo, Javier
    Redondo Marguello, Esther
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (01) : 1 - 11
12345